102 related articles for article (PubMed ID: 20838295)
1. Midline cyst of the prostate mimicking malignancy on FDG PET/CT.
Kim DW; Jung SA; Park SA; Kim CG
Clin Nucl Med; 2010 Oct; 35(10):811-2. PubMed ID: 20838295
[TBL] [Abstract][Full Text] [Related]
2. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
Jadvar H; Henderson RW; Conti PS
J Comput Assist Tomogr; 2007; 31(2):223-8. PubMed ID: 17414758
[TBL] [Abstract][Full Text] [Related]
3. Squamous cell carcinoma of the prostate with strong FDG uptake on PET/CT.
Dong A; Zuo C; Lu J; Wang Y
Clin Nucl Med; 2014 Jul; 39(7):650-2. PubMed ID: 23877521
[TBL] [Abstract][Full Text] [Related]
4. Widespread metastases in small cell carcinoma of the prostate on FDG PET/CT.
Yilmaz M; Celen Z; Sevinc A; Karakok M
Clin Nucl Med; 2009 Sep; 34(9):598-600. PubMed ID: 19692822
[TBL] [Abstract][Full Text] [Related]
5. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
6. Positron emission tomography and bone metastases.
Fogelman I; Cook G; Israel O; Van der Wall H
Semin Nucl Med; 2005 Apr; 35(2):135-42. PubMed ID: 15765376
[TBL] [Abstract][Full Text] [Related]
7. FDG PET in suspected recurrent and metastatic prostate cancer.
Jadvar H; Pinski JK; Conti PS
Oncol Rep; 2003; 10(5):1485-8. PubMed ID: 12883728
[TBL] [Abstract][Full Text] [Related]
8. [PET/CT with (11)C-choline and (18)F-FDG in patients with elevated PSA after radical treatment of a prostate cancer].
García JR; Soler M; Blanch MA; Ramírez I; Riera E; Lozano P; Pérez X; Delgado E; Carrio I; Lomeña F
Rev Esp Med Nucl; 2009; 28(3):95-100. PubMed ID: 19558948
[TBL] [Abstract][Full Text] [Related]
9. The 18F-FDG PET/CT finding of a condyloma acuminata mimicking primary anorectal carcinoma in an HIV-infected patient.
Kim BS
Clin Nucl Med; 2013 Oct; 38(10):e402-3. PubMed ID: 22996249
[TBL] [Abstract][Full Text] [Related]
10. Metastatic colon cancer to the lung with no detectable primary tumor, mimicking advanced primary lung cancer on F-18 FDG PET/CT imaging.
Kim HW; Won KS; Kwon KY; Choi BW; Zeon SK
Clin Nucl Med; 2010 Mar; 35(3):184-6. PubMed ID: 20173453
[TBL] [Abstract][Full Text] [Related]
11. [18F]Fluorodeoxyglucose positron emission tomography surveillance of hepatic metastases from prostate cancer following radiofrequency ablation: a case report.
Ludwig V; Hopper OW; Martin WH; Kikkawa R; Delbeke D
Am Surg; 2003 Jul; 69(7):593-8. PubMed ID: 12889623
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
[TBL] [Abstract][Full Text] [Related]
13. F-18 FDG PET/CT imaging of solitary genital tuberculosis mimicking recurrent lymphoma.
Lee G; Lee JH; Park SG
Clin Nucl Med; 2011 Apr; 36(4):315-6. PubMed ID: 21368612
[TBL] [Abstract][Full Text] [Related]
14. Novel strategy for a cocktail 18F-fluoride and 18F-FDG PET/CT scan for evaluation of malignancy: results of the pilot-phase study.
Iagaru A; Mittra E; Yaghoubi SS; Dick DW; Quon A; Goris ML; Gambhir SS
J Nucl Med; 2009 Apr; 50(4):501-5. PubMed ID: 19289439
[TBL] [Abstract][Full Text] [Related]
15. Use of FDG PET-CT in prostate lesion diagnosis.
Radiol Technol; 2014; 85(5):546M-547M. PubMed ID: 24806072
[No Abstract] [Full Text] [Related]
16. Pilot comparison of F-fluorocholine and F-fluorodeoxyglucose PET/CT with conventional imaging in prostate cancer.
Beauregard JM; Williams SG; Degrado TR; Roselt P; Hicks RJ
J Med Imaging Radiat Oncol; 2010 Aug; 54(4):325-32. PubMed ID: 20718912
[TBL] [Abstract][Full Text] [Related]
17. FDG-PET/CT in evaluation and prognostication of primary prostate lymphoma.
Hodgson R; Huang YT; Steinke K; Ravi Kumar AS
Clin Nucl Med; 2010 Jun; 35(6):418-20. PubMed ID: 20479589
[No Abstract] [Full Text] [Related]
18. FDG PET imaging in a patient with primary seminoma of the prostate.
Hayasaka K; Koyama M; Fukui I
Clin Nucl Med; 2011 Jul; 36(7):593-4. PubMed ID: 21637070
[TBL] [Abstract][Full Text] [Related]
19. The potential of FDG-PET/CT for detecting prostate cancer in patients with an elevated serum PSA level.
Minamimoto R; Uemura H; Sano F; Terao H; Nagashima Y; Yamanaka S; Shizukuishi K; Tateishi U; Kubota Y; Inoue T
Ann Nucl Med; 2011 Jan; 25(1):21-7. PubMed ID: 20931305
[TBL] [Abstract][Full Text] [Related]
20. [18F-FDG PET/CT diagnosis of liver cyst infection in a patient with autosomal dominant polycystic kidney disease and fever of unknown origin].
Banzo J; Ubieto MA; Gil D; Prats E; Razola P; Tardín L; Andrés A; Rambalde EF; Ayala SM; Cáncer L; Velilla J
Rev Esp Med Nucl Imagen Mol; 2013; 32(3):187-9. PubMed ID: 23153986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
